Isabelle Pouliquen - Concepedia

Author

Isabelle Pouliquen

Also Known As

I Pouliquen, I. J. Pouliquen, I. Pouliquen, ISABELLE POULIQUEN, Isabelle J Pouliquen, Isabelle J. Pouliquen, Isabelle POULIQUEN, Isabelle Pouliquen, Pouliquen, Isabelle

Publications

960

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation GlaxoSmithKline (United Kingdom)GlaxoSmithKline (United States)Age UK PAREXEL International (United Kingdom)

About

Isabelle Pouliquen is an author at Research Triangle Park Foundation specializing in medicine, pharmacotherapy, and asthma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	263
2	Allergy	3	3	195
3	Health Sciences	1	1	23
4	Public Health	1	1	33
5	Social Sciences	1	1	33

Isabelle Pouliquen

Publications

843

Citations

H-Index

Page 1

	Year	Citations
A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar Trihydrochloride (LY335979), Administered Intravenously in Combination with Doxorubicin in Patients with Advanced Malignancy Alan Sandler, Michael A. Gordon, Dinesh P. de Alwis, Clinical Cancer Research	2004	150
Efficacy and safety of an anti–IL-13 mAb in patients with severe asthma: A randomized trial Erika H. De Boever, Claire Ashman, Anthony Cahn, Journal of Allergy and Clinical Immunology Clinical ImmunologyAsthmaAllergyAllergy MedicineImmunology	2014	142
Subcutaneous mepolizumab in children aged 6 to 11 years with severe eosinophilic asthma Atul Gupta, Isabelle Pouliquen, Daren Austin, Pediatric Pulmonology	2019	86
Characterization of the relationship between dose and blood eosinophil response following subcutaneous administration of mepolizumab Isabelle Pouliquen, Oliver Kornmann, Sharon V. Barton, International Journal of Clinical Pharmacology and Therapeutics	2015	83
A phase 1, randomized, placebo‐controlled, dose‐escalation study of an anti‐IL‐13 monoclonal antibody in healthy subjects and mild asthmatics Peter Hodsman, Claire Ashman, Anthony Cahn, British Journal of Clinical Pharmacology	2012	57
A Phase 1 study of the long‐acting anti‐IL‐5 monoclonal antibody GSK3511294 in patients with asthma Dave Singh, Rainard Fuhr, Nicholas Bird, British Journal of Clinical Pharmacology	2021	50
Safety, tolerability, pharmacokinetics, and pharmacodynamics of single-dose antiinterleukin- 18 mAb GSK1070806 in healthy and obese subjects Prafull Mistry, Juliet Reid, Isabelle Pouliquen, International Journal of Clinical Pharmacology and Therapeutics	2014	41
Usability of mepolizumab single-use prefilled syringe for patient self-administration Elisabeth H. Bel, David I. Bernstein, Leif Bjermer, Journal of Asthma	2019	33
Assessing efficacy in important subgroups in confirmatory trials: An example using Bayesian dynamic borrowing Nicky Best, Robert G. Price, Isabelle Pouliquen, Pharmaceutical Statistics Robust MixtureBehavioral Decision MakingPrior Knowledge IncorporationField ExperimentImportant Subgroups	2021	33
Pharmacokinetics and pharmacodynamics of mepolizumab, an anti–interleukin 5 monoclonal antibody, in healthy Japanese male subjects Naohiro Tsukamoto, Naoki Takahashi, Hiroshi Itoh, Clinical Pharmacology in Drug Development Clinical ImmunologyAsthmaAllergy MedicineImmunodeficienciesImmunology	2015	32

Page 1